Cormorant Asset Management’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-72,042
| Closed | -$458K | – | 63 |
|
|
2023
Q1 | $458K | Hold |
72,042
| – | – | 0.03% | 69 |
|
|
2022
Q4 | $922K | Hold |
72,042
| – | – | 0.06% | 64 |
|
|
2022
Q3 | $718K | Hold |
72,042
| – | – | 0.05% | 66 |
|
|
2022
Q2 | $1.07M | Hold |
72,042
| – | – | 0.08% | 69 |
|
|
2022
Q1 | $1.38M | Buy |
+72,042
| New | +$1.38M | 0.11% | 71 |
|